Kolexia
Nicolino Marc Pédiatrie
Nicolino Marc
Pédiatrie
Hôpital Femme Mère Enfant
Bron, France
157 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 1 Diabète Obésité Ostéochondrodysplasies Troubles de la croissance Achondroplasie Syndrome de Prader-Willi Maladies auto-immunes Dysplasie fibreuse polyostotique

Collaborateurs

Voir plus
Coutant Regis
Coutant Regis
Hôpital Larrey Angers, Angers, France
Plotton Ingrid
Plotton Ingrid
Hôpital Pierre Wertheimer, Bron, France
Bendelac Nathalie
Bendelac Nathalie
Hôpital Femme Mère Enfant, Bron, France
Perge Kevin
Perge Kevin
Hôpital Femme Mère Enfant, Bron, France

Industries

Voir plus
B3TSI
63 collaboration(s)
Dernière en 2023
A+A
20 collaboration(s)
Dernière en 2023
Sanofi
16 collaboration(s)
Dernière en 2023
P\S\L Group Services
14 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH): Prospective Clinical Assessment Study in Children With Achondroplasia: The PROPEL Trial
Essai Clinique (QED Therapeutics, Inc.)   30 janvier 2024
Ciliopathy due to POC1A deficiency: clinical and metabolic features, and cellular modeling.
European journal of endocrinology   20 janvier 2024
Hypoventilation in patients with Prader-Willi syndrome across the pediatric age.
Pediatric pulmonology   05 janvier 2024
RADIANT: Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)
Essai Clinique (Insulet Corporation)   04 décembre 2023
OR27-03 Oral Infigratinib Treatment Is Well Tolerated And Significantly Increases Height Velocity In Children With Achondroplasia: Month 6 Results From The PROPEL 2 Dose-finding Study
ENDO 2023 Abstracts Annual Meeting of the Endocrine Society   05 octobre 2023
THU181 Evaluation Of Bone Mineral Density In A Cohort Of Children With ACH Participating In The PROPEL 2 Study Of Infigratinib
ENDO 2023 Abstracts Annual Meeting of the Endocrine Society   05 octobre 2023
THU165 PROPEL, PROPEL 2 And PROPEL OLE Studies Of Infigratinib In Children With Achondroplasia: Design And Status Of 3 Ongoing Trials
ENDO 2023 Abstracts Annual Meeting of the Endocrine Society   05 octobre 2023
PROTECT: Phase 3 Randomized Double-Blind Multinational Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab, a Humanized FcR Non-Binding Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Essai Clinique (Provention Bio, Inc.)   23 août 2023
Objective burden and emotional distress in parents of children with type 1 diabetes.
Hormone research in paediatrics   13 juillet 2023
IDMet: National Cohort on Imprinting Disorders and Their Metabolic Consequences
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   06 juillet 2023